Discovery of Pyrazolo[1,5-a]pyrimidine derivative as a potent and selective PI3K?/6 dual inhibitor

被引：3

作者：

Liang, Xiaofei ^{[1
,2
]}

Deng, Maoqing ^{[1
,2
,3
]}

Zou, Fengming ^{[1
,2
]}

Qi, Ziping ^{[1
,2
]}

Wang, Chun ^{[1
,3
]}

Liu, Juan ^{[1
,2
]}

Liu, Qingwang ^{[1
,2
]}

Wang, Beilei ^{[1
,2
]}

Qi, Shuang ^{[1
,2
]}

Ge, Juan ^{[1
,3
]}

Yu, Hongwei ^{[1
,3
]}

Wang, Aoli ^{[1
,2
]}

Liu, Qingsong ^{[1
,2
,3
,4
,5
]}

Liu, Jing ^{[1
,2
,3
,4
,5
]}

机构：

[1] Chinese Acad Sci, Inst Hlth & Med Technol, Hefei Inst Phys Sci, Anhui Prov Key Lab Med Phys & Technol, Hefei 230031, Anhui, Peoples R China

[2] Chinese Acad Sci, Hefei Canc Hosp, Hefei 230031, Anhui, Peoples R China

[3] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China

[4] Precis Med Res Lab Anhui Prov, Hefei 230088, Anhui, Peoples R China

[5] Chinese Acad Sci, Hefei Inst Phys Sci, Hefei 230031, Anhui, Peoples R China

来源：

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 260卷

基金：

中国国家自然科学基金;

关键词：

PI3K-GAMMA; INFLAMMATION; RESISTANCE; PI3K-DELTA; ISOFORM;

D O I：

10.1016/j.ejmech.2023.115768

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Phosphoinositol 3-kinases (PI3Ks) & gamma; and 6 are primarily expressed in leukocytes and play crucial roles in regulation of the immune system. Dual inhibition of PI3K & gamma;/6 has emerged as an effective approach to regulate the tumor microenvironment. Here, we report the exploration of structure-activity relationship optimization which led to the discovery of a potent PI3K & gamma;/6 dual inhibitor 15u (IHMT-PI3K-455). 15u exhibits strong potency in biochemical and cellular assays and it repolarizes M2 phenotype toward M1 phenotype in THP-1 and BMDM macrophages. In addition, it shows suitable in vivo properties as demonstrated through pharmacokinetic studies in rats and pharmacodynamics properties in a MC38 xenograft model.

引用

页数：16

共 50 条

[31] Discovery and optimization of heteroaryl piperazines as potent and selective PI3Kδ inhibitors
Zhou, Hua
McGowan, Meredeth A.
Lipford, Kathryn
Christopher, Matthew
Fradera, Xavier
Witter, David
Lesburg, Charles A.
Li, Chaomin
Methot, Joey L.
Lampe, John
Achab, Abdelghani
Shaffer, Lynsey
Goldenblatt, Peter
Shah, Sanjiv
Bass, Alan
Schroeder, Gottfried
Chen, Dapeng
Zeng, Haoyu
Augustin, Martin A.
Katz, Jason D.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (01)
[32] Optimization and in vivo evaluation of pyrazolopyridines as a potent and selective PI3Kδ inhibitor
Hamajima, Toshihiro
Takahashi, Fumie
Kato, Koji
Sugano, Yukihito
Yamaki, Susumu
Moritomo, Ayako
Kubo, Satoshi
Nakamura, Koji
Yamagami, Kaoru
Hamakawa, Nozomu
Yokoo, Koji
Fukahori, Hidehiko
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (14) : 3917 - 3924
[33] Pyrazolo[1,5-a]pyrimidine TRPC6 antagonists for the treatment of gastric cancer
Ding, Mingmin
Wang, Hongbo
Qu, Chunrong
Xu, Fuchun
Zhu, Yingmin
Lv, Guangyao
Lu, Yungang
Zhou, Qingjun
Zhou, Hui
Zeng, Xiaodong
Zhang, Jingwen
Yan, Chunhong
Lin, Jiacheng
Luo, Huai-Rong
Deng, Zixing
Xiao, Yuling
Tian, Jinbin
Zhu, Michael X.
Hong, Xuechuan
CANCER LETTERS, 2018, 432 : 47 - 55
[34] NOVEL TYPE OF ISOMERIZATIONAL RECYCLIZATION OF PYRAZOLO[1,5-a]PYRIMIDINE TO PYRAZOLO-[1,5-b][1,2,4]TRIAZINE DERIVATIVE
Danagulyan, G. G.
Boyakhchyan, A. P.
Tumanyan, A. K.
Danagulyan, A. G.
Kirakosyan, V. G.
CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2011, 47 (03) : 386 - 389
[35] The discovery of the potent and selective PI3K/mTOR dual inhibitor PF-04691502 through structure-based drug design
Cheng, Henry
Bagrodia, Shubha
Bailey, Simon
Bhumalkar, Dilip
Dress, Klaus
Edwards, Martin
Gehring, Michael R.
Guo, Lisa
Hoffman, Jacqui
Hu, Qiyue
Huang, Xiaojun
Johnson, Catherine
Johnson, Ted O.
Kania, Robert
Knighton, Daniel R.
Phuong Le
Li, Haitao
Li, Samuel
Liu, Kevin
Liu, Zhengyu
Marx, Matthew A.
Nambu, Mitch
Ninkovic, Sacha
Nowlin, Dawn
Pairish, Mason
Pannifer, Andrew
Plewe, Michael
Rodgers, Caroline
Smith, Graham
Sun, Shaoxian
Khanh Tran
Wang, Hai
Zbieg, Jason
Zhu, Peter
CANCER RESEARCH, 2010, 70
[36] SYNTHESIS OF 1H-PYRAZOLO[3,4-B]PYRIDINE AND PYRAZOLO[1,5-A]PYRIMIDINE
VANHAVERBEKE, Y
MAQUESTIAU, A
VANDENEYNDE, JJ
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1979, 16 (04) : 773 - 777
[37] RING TRANSFORMATION OF 6H-CYCLOPROPA [E] PYRAZOLO [1,5-A] PYRIMIDINE .5. SYNTHESIS OF 4H-PYRAZOLO [1,5-A] [1,3] DIAZEPINE
KURIHARA, T
KAWASAKI, E
NASU, K
HETEROCYCLES, 1983, 20 (10) : 1913 - 1916
[38] Novel type of isomerizational recyclization of pyrazolo[1,5-a]pyrimidine to pyrazolo-[1,5-b][1,2,4]triazine derivative
G. G. Danagulyan
A. P. Boyakhchyan
A. K. Tumanyan
A. G. Danagulyan
V. G. Kirakosyan
Chemistry of Heterocyclic Compounds, 2011, 47 : 386 - 389
[39] NOVEL REARRANGEMENT OF 3-CYANOPYRAZOLO[1,5-A]PYRIMIDINE TO A PYRAZOLO[3,4-D]PYRIMIDINE
NOVINSON, T
ROBINS, RK
OBRIEN, DE
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1973, 10 (05) : 887 - 887
[40] Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor
Hwang, Jong Yeon
Windisch, Marc Peter
Jo, Suyeon
Kim, Keumhyun
Kong, Sunju
Kim, Hyoung Cheul
Kim, Soohyun
Kim, Heeyoung
Lee, Myung Eun
Kim, Youngmi
Choi, Jihyun
Park, Dong-Sik
Park, Eunjung
Kwon, Jeongjin
Nam, Jiyoun
Ahn, Sujin
Cechetto, Jonathan
Kim, Junwon
Liuzzi, Michel
No, Zaesung
Lee, Jinhwa
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (24) : 7297 - 7301

← 1 2 3 4 5 →